Total Payments
$2,054
2022 Payments
$16.00
Companies
8
Transactions
21
Medicare Patients
7,322
Medicare Billing
$202,808
Payment Breakdown by Category
Travel$1,392 (67.8%)
Food & Beverage$661.75 (32.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,392 | 7 | 67.8% |
| Food and Beverage | $661.75 | 14 | 32.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $884.73 | 9 | $0 (2020) |
| GE Healthcare | $768.04 | 4 | $0 (2018) |
| Novo Nordisk Inc | $194.89 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $71.01 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $54.46 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $50.35 | 1 | $0 (2017) |
| VYERA PHARMACEUTICALS, LLC | $16.00 | 1 | $0 (2022) |
| Siemens Medical Solutions USA, Inc. | $14.47 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $16.00 | 1 | VYERA PHARMACEUTICALS, LLC ($16.00) |
| 2020 | $884.73 | 9 | Merck Sharp & Dohme Corporation ($884.73) |
| 2019 | $67.16 | 1 | Novo Nordisk Inc ($67.16) |
| 2018 | $851.52 | 6 | GE Healthcare ($768.04) |
| 2017 | $234.54 | 4 | Novartis Pharmaceuticals Corporation ($71.01) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2022 | VYERA PHARMACEUTICALS, LLC | Daraprim (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Toxoplasmosis | ||||||
| 01/15/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Food and Beverage | In-kind items and services | $64.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/15/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Food and Beverage | In-kind items and services | $48.49 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/15/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Food and Beverage | In-kind items and services | $39.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/15/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Food and Beverage | Cash or cash equivalent | $17.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/14/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Travel and Lodging | In-kind items and services | $323.97 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/14/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Travel and Lodging | In-kind items and services | $226.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/14/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Travel and Lodging | Cash or cash equivalent | $73.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/14/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Food and Beverage | In-kind items and services | $64.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/14/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/18/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $67.16 | General |
| Category: Diabetes | ||||||
| 07/20/2018 | Siemens Medical Solutions USA, Inc. | MAGNETOM Aera (Device) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: MR - MRI | ||||||
| 04/25/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $69.01 | General |
| Category: Diabetes | ||||||
| 02/17/2018 | GE Healthcare | — | Travel and Lodging | Cash or cash equivalent | $547.36 | General |
| Category: DETECTION & GUIDANCE SOLUTIONS | ||||||
| 02/17/2018 | GE Healthcare | — | Travel and Lodging | Cash or cash equivalent | $149.28 | General |
| Category: DETECTION & GUIDANCE SOLUTIONS | ||||||
| 02/17/2018 | GE Healthcare | — | Travel and Lodging | Cash or cash equivalent | $65.40 | General |
| Category: DETECTION & GUIDANCE SOLUTIONS | ||||||
| 02/17/2018 | GE Healthcare | — | Travel and Lodging | Cash or cash equivalent | $6.00 | General |
| Category: DETECTION & GUIDANCE SOLUTIONS | ||||||
| 11/02/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $58.72 | General |
| Category: Diabetes | ||||||
| 06/20/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $54.46 | General |
| Category: DIABETES | ||||||
| 04/18/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $50.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $71.01 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,241 | 1,368 | $209,163 | $32,510 |
| 2022 | 38 | 1,660 | 1,840 | $273,867 | $41,618 |
| 2021 | 36 | 1,756 | 1,991 | $308,955 | $50,164 |
| 2020 | 46 | 2,665 | 3,394 | $470,784 | $78,516 |
Total Patients
7,322
Total Services
8,593
Medicare Billing
$202,808
Procedure Codes
170
All Medicare Procedures & Services
170 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Facility | 2023 | 194 | 194 | $29,100 | $6,806 | 23.4% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 90 | 101 | $33,532 | $5,603 | 16.7% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 111 | 127 | $26,289 | $3,192 | 12.1% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Facility | 2023 | 37 | 37 | $14,282 | $2,430 | 17.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 40 | 40 | $12,480 | $2,097 | 16.8% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 208 | 274 | $11,234 | $1,535 | 13.7% |
| 72148 | Mri scan of lower spinal canal without contrast | Facility | 2023 | 30 | 31 | $8,556 | $1,439 | 16.8% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 23 | 23 | $8,004 | $1,405 | 17.5% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 34 | 34 | $7,956 | $963.10 | 12.1% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 12 | 13 | $4,966 | $801.36 | 16.1% |
| 76641 | Complete ultrasound scan of 1 breast | Facility | 2023 | 28 | 28 | $6,716 | $770.22 | 11.5% |
| 70551 | Mri scan of brain without contrast | Facility | 2023 | 15 | 16 | $4,416 | $768.18 | 17.4% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2023 | 24 | 24 | $5,736 | $648.22 | 11.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 48 | 48 | $2,496 | $430.29 | 17.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 15 | 15 | $4,095 | $409.08 | 10.0% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 14 | 14 | $2,100 | $385.32 | 18.3% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 20 | 20 | $7,000 | $364.12 | 5.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 48 | 50 | $2,350 | $338.94 | 14.4% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2023 | 14 | 14 | $2,660 | $298.92 | 11.2% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 43 | 45 | $2,115 | $282.45 | 13.4% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 19 | 21 | $4,221 | $281.97 | 6.7% |
| 73502 | X-ray of hip, 2-3 views | Facility | 2023 | 21 | 25 | $1,150 | $183.04 | 15.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 20 | 20 | $1,040 | $158.08 | 15.2% |
| 73562 | X-ray of knee, 3 views | Facility | 2023 | 26 | 31 | $1,271 | $140.00 | 11.0% |
| 73030 | X-ray of shoulder, minimum of 2 views | Facility | 2023 | 18 | 21 | $882.00 | $119.00 | 13.5% |
About Dr. Mario Castillo, MD
Dr. Mario Castillo, MD is a Diagnostic Radiology healthcare provider based in Big Spring, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992786321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mario Castillo, MD has received a total of $2,054 in payments from pharmaceutical and medical device companies, with $16.00 received in 2022. These payments were reported across 21 transactions from 8 companies. The most common payment nature is "Travel and Lodging" ($1,392).
As a Medicare-enrolled provider, Castillo has provided services to 7,322 Medicare beneficiaries, totaling 8,593 services with total Medicare billing of $202,808. Data is available for 4 years (2020–2023), covering 170 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Diagnostic Radiology
- Location Big Spring, TX
- Active Since 11/11/2005
- Last Updated 03/06/2024
- Taxonomy Code 2085R0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992786321
Products in Payments
- MK-8591A (Drug) $884.73
- Victoza (Drug) $127.73
- ENTRESTO (Drug) $71.01
- Ozempic (Drug) $67.16
- SOLIQUA (Drug) $54.46
- FARXIGA (Drug) $50.35
- Daraprim (Drug) $16.00
- MAGNETOM Aera (Device) $14.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.